GlassScriptPhysician profile
Hitesh C Patel
NPI 1831191246
$16,528.33
in general payments reported to CMS, 2019-2025
91 companies · $3,493 in 2025
The $3,493 reported for 2025 was more than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,652 · 2020: $1,570 · 2021: $1,911 · 2022: $1,784 · 2023: $1,981 · 2024: $4,138 · 2025: $3,493.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,805 · Long Term Medical Supply Or Device Loan: $1,347 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $433 · Education: $26.11.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,805.42 |
| Long Term Medical Supply Or Device Loan | $1,346.69 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $433.33 |
| Education | $26.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,148.93 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $961.69 | 2019-2025 | Imfinzi, Enhertu, Lynparza |
| Merck Sharp & Dohme LLC | $844.47 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Pfizer INC. | $803.84 | 2019-2025 | |
| Genzyme Corporation | $738.71 | 2019-2025 | |
| Janssen Biotech, INC. | $641.59 | 2019-2025 | Rybrevant, Darzalex, Talvey |
| E.R. Squibb & Sons, L.L.C. | $563.18 | 2019-2025 | Opdivo, Opdualag |
| Daiichi Sankyo INC. | $544.59 | 2019-2025 | Enhertu, Datroway |
| Incyte Corporation | $535.08 | 2019-2025 | Jakafi, Monjuvi |
| Seagen INC. | $477.52 | 2019-2023 | Tukysa, Adcetris, Padcev |
| Lilly USA, LLC | $467.77 | 2019-2025 | Verzenio, Jaypirca, Retevmo |
| Celgene Corporation | $396.46 | 2019-2024 | Reblozyl |
| Gilead Sciences, INC. | $374.90 | 2019-2025 | Trodelvy |
| Astellas Pharma US INC | $311.62 | 2019-2025 | Xtandi, Xospata, Padcev |
| Abbvie INC. | $309.39 | 2019-2025 |
Show all 91 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $306.79 | 2019-2023 | Lumakras |
| Bayer Healthcare Pharmaceuticals INC. | $299.35 | 2019-2025 | |
| Glaxosmithkline, LLC. | $291.74 | 2020-2025 | Ojjaara, Zejula, Jemperli |
| Takeda Pharmaceuticals U.S.A., INC. | $290.27 | 2019-2025 | Fruzaqla, Vpriv, Alunbrig |
| Eisai INC. | $283.67 | 2019-2025 | |
| Regeneron Healthcare Solutions, INC. | $278.27 | 2022-2025 | Libtayo |
| Genentech USA, INC. | $278.02 | 2019-2025 | Alecensa, Tecentriq, Tecentriq Hybreza |
| Array Biopharma INC | $182.45 | 2019-2025 | Braftovi, Mektovi, Lorbrena |
| Exelixis INC. | $180.89 | 2019-2025 | Cabometyx |
| Csl Behring | $173.04 | 2021-2025 | Afstyla, Idelvion |
| Pharmacosmos Therapeutics INC. | $159.88 | 2024-2025 | Monoferric, Cosela |
| Kite Pharma, INC. | $130.75 | 2021-2023 | Yescarta |
| Pharmacyclics LLC, An Abbvie Company | $125.45 | 2019-2023 | Imbruvica |
| Beigene USA, INC. | $125.09 | 2021-2024 | Brukinsa |
| Tersera Therapeutics LLC | $124.87 | 2019-2024 | Zoladex |
| Aveo Pharmaceuticals, INC. | $123.90 | 2021-2025 | |
| Pharmaessentia USA Corporation | $118.05 | 2022-2025 | Besremi |
| Emd Serono, INC. | $114.85 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $112.03 | 2020-2021 | |
| Rigel Pharmaceuticals, INC. | $107.59 | 2019-2025 | Rezlidhia, Gavreto, Tavalisse |
| Dendreon Pharmaceuticals LLC | $107.56 | 2022-2025 | Provenge |
| Janssen Pharmaceuticals, INC | $106.72 | 2019-2020 | |
| Puma Biotechnology, INC. | $104.65 | 2021-2024 | |
| Ipsen Biopharmaceuticals, INC | $100.78 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $98.04 | 2023-2025 | Orgovyx |
| Stemline Therapeutics INC. | $94.54 | 2023-2025 | Orserdu |
| Genmab U.S., INC. | $92.97 | 2023-2024 | Epkinly |
| Beone Medicines USA, INC. | $89.84 | 2025 | Brukinsa |
| Agios Pharmaceuticals, INC. | $76.56 | 2019-2024 | Pyrukynd |
| Karyopharm Therapeutics INC. | $76.04 | 2020-2023 | Xpovio |
| Sobi, INC | $75.61 | 2022-2024 | |
| Foundation Medicine, INC. | $71.60 | 2019-2023 | |
| Jazz Pharmaceuticals INC. | $71.59 | 2021-2025 | Zepzelca |
| Kyowa Kirin, INC. | $70.89 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $69.81 | 2020-2021 | |
| Deciphera Pharmaceuticals INC. | $68.64 | 2021-2025 | Qinlock, Romvimza |
| Amag Pharmaceuticals, INC. | $67.23 | 2020-2022 | |
| Ge Healthcare | $62.13 | 2021 | |
| Alexion Pharmaceuticals, INC. | $60.96 | 2024-2025 | Ultomiris |
| Blueprint Medicines Corporation | $60.62 | 2021-2025 | Ayvakit |
| Tesaro, INC. | $53.92 | 2019 | |
| Myovant Sciences INC. | $52.65 | 2021-2022 | |
| Geron Corporation | $52.02 | 2025 | Rytelo |
| Taiho Oncology, INC. | $50.94 | 2020-2024 | |
| G1 Therapeutics, INC. | $45.75 | 2022-2023 | Cosela |
| Dova Pharmaceuticals | $45.02 | 2021 | |
| Tempus Ai, INC | $41.00 | 2024 | Xt Cdx |
| Morphosys, US INC. | $36.42 | 2022-2023 | Monjuvi |
| Legend Biotech USA INC. | $36.21 | 2025 | Carvykti |
| Epizyme, INC. | $35.51 | 2021-2022 | |
| Adc Therapeutics America, INC. | $31.79 | 2022 | |
| Recordati_rare_diseases_inc. | $31.60 | 2025 | Enjaymo |
| Servier Pharmaceuticals LLC | $31.29 | 2021-2022 | |
| Sun Pharmaceutical Industries INC. | $30.32 | 2022-2023 | Odomzo, Yonsa |
| Springworks Therapeutics, INC. | $28.07 | 2024 | Ogsiveo |
| Immunocore Limited | $27.61 | 2025 | Kimmtrak |
| Napo Pharmaceuticals INC | $26.90 | 2025 | Gelclair Concentrated Oral Gel |
| Sirtex Medical INC | $26.32 | 2019-2020 | |
| Alnylam Pharmaceuticals INC. | $23.24 | 2023 | Givlaari |
| Syndax Pharmaceuticals, INC. | $21.86 | 2025 | |
| Tg Therapeutics, INC. | $21.46 | 2021 | |
| Shire North American Group INC | $20.83 | 2019 | |
| Mirati Therapeutics, INC. | $17.74 | 2023 | Krazati |
| Lexicon Pharmaceuticals, INC. | $17.73 | 2019 | |
| Cti Biopharma Corp. | $17.32 | 2023 | Vonjo |
| Immunomedics, INC. | $16.44 | 2020 | |
| Adaptive Biotechnologies Corporation | $15.75 | 2022 | |
| Acceleron Pharma, INC. | $15.24 | 2021 | |
| Verity Pharmaceuticals INC. | $14.96 | 2023 | Trelstar |
| Acrotech Biopharma INC. | $14.26 | 2021 | |
| Novocure INC. | $13.82 | 2025 | Optune Lua (Novottf-200t) |
| Verastem, INC. | $13.58 | 2019 | |
| Shield Therapeutics INC | $13.55 | 2024 | |
| Clovis Oncology, INC. | $13.19 | 2019 | |
| Aurobindo Pharma USA, INC. | $11.95 | 2020 | |
| Pharmaand Gmbh | $8.60 | 2025 | Rubraca |
Drugs and devices associated with these payments
Kisqali $1,449Keytruda $477Enhertu $460Inlyta $424Sarclisa $321Jakafi $306Adcetris $239Libtayo $235Opdivo $210Imfinzi $208Elrexfio $194Tukysa $191Reblozyl $190Brukinsa $168Padcev $165Jaypirca $146Verzenio $146Ojjaara $145Braftovi $139Lynparza $139Fruzaqla $139Scemblix $137Bosulif $136Lutathera $130Rybrevant $129Xtandi $127Mektovi $124Venclexta $122Imbruvica $118Afstyla $107Idelvion $107Pluvicto $102Besremi $99.15Monoferric $98.77Orgovyx $98.04Cabometyx $97.00Orserdu $94.54Trodelvy $94.24Epkinly $92.97Rezlidhia $92.26Tavalisse $92.26Provenge $90.54Lorbrena $90.50Monjuvi $84.91Lenvima $82.23Fotivda $81.56Zoladex $81.43Nubeqa $78.79Darzalex $78.42Cosela $78.23Ibrance $73.75Fabhalta $67.91Enjaymo $67.17Gavreto $63.84Ultomiris $60.96Xofigo $54.82Zejula $54.25Jemperli $54.25Rytelo $52.02Vpriv $49.89Ayvakit $49.26Calquence $48.02Vonjo $46.40Opdualag $44.09Xt Cdx $41.00Welireg $40.58Retevmo $39.95Talvey $38.83Carvykti $36.21Tecvayli $36.10Cablivi $35.57Doptelet $34.42Xospata $34.04Alunbrig $33.85Erleada $32.54Balversa $32.54Blenrep $30.96Keytruda Qlex $30.67Tecentriq Hybreza $30.02Tecentriq $30.02Polivy $30.02Alecensa $30.02Datroway $29.65Ogsiveo $28.07Kimmtrak $27.61Mekinist $27.33Gelclair Concentrated Oral Gel $26.90Talzenna $26.30Xpovio $26.18Ziihera $24.69Vitrakvi $23.97Stivarga $23.97Givlaari $23.24Elitek $23.01Yescarta $20.86Lumakras $20.65Pyrukynd $20.59Qinlock $20.06Romvimza $20.06Tasigna $17.90
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hitesh Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.